Nicotinamide Supports NK Cellular Therapy in NHL
Researchers sought to determine whether expansion of NK cells with IL-15 and nicotinamide would improve responses in patients with NHL and MM.
Diagnosis & Disease Information
Carcinogens Found at Montana Nuclear Missile Base as Cancer Cases Rise Nearby
Levels of polychlorinated biphenyls were higher than the threshold recommended by the Environmental Protection Agency.
Lenalidomide Maintenance Not Recommended After ASCT in High-Risk Non-Hodgkin Lymphoma
Researchers sought to determine whether lenalidomide maintenance would improve outcomes in patients with high-risk non-Hodgkin lymphoma who receive HDT/ASCT .
Adding Ibrutinib to Induction and Maintenance Improves FFS in Mantle Cell Lymphoma
Adding ibrutinib to induction and maintenance after transplant improves failure-free survival in patients with mantle cell lymphoma, results of the TRIANGLE study suggest.
Glofitamab Can Provide Lasting Remissions in Heavily Pretreated Large B-Cell Lymphoma
Progression is “uncommon” in patients with relapsed/refractory large B-cell lymphoma who are in complete remission at the end of glofitamab treatment.
Remote Assessment of Cognitive Function Feasible With Hematologic Malignancies
Researchers sought to evaluate cognitive function in patients with hematologic cancers and the feasibility conducting cognitive assessments remotely in these patients.
Atezolizumab Plus R-CHOP Deemed Unworthy of Additional Study in Diffuse Large B-Cell Lymphoma
Results of a phase 1/2 trial suggest the combination of atezolizumab and R-CHOP does not warrant further study in DLBCL, according to researchers.
Outcomes After BTK Inhibitor Failure in Rel/Ref Mantle Cell Lymphoma
A real-world study provides a benchmark for survival in MCL patients for whom BTK inhibitor treatment has failed, according to researchers.
Ultra-Low-Dose Radiation Appears Effective in Orbital Indolent B-Cell Lymphoma
Response-adapted ultra-low-dose radiation therapy demonstrated efficacy and negligible toxicity in orbital indolent B-cell lymphoma.
Cutaneous T-Cell Lymphoma Incidence on the Rise in the United States
The incidence of cutaneous T-cell lymphoma in the United States increased from 2000 to 2018, with an annual percent change of 0.61%.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...